Headline
The latest stories from AHA Today.
AT&T, T-Mobile and Verizon are retiring their 3G networks, which could impact fire alarm and other building communication systems that use 3G service, the AHA’s American Society for Health Care Engineering advised members.
Fresenius Kabi USA recalledseven lots of sodium acetate injection after finding particulate matter in sample vials, which could cause infection or other serious adverse events if administered. No adverse events were reported.
The Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration and Office of Minority Health plan to award $35 million through seven grant programs to support mental health and suicide prevention for children and young adults, including $9.2 million from the…
The House Appropriations Committee announced an agreement on omnibus appropriations legislation funding the federal government through the end of the current fiscal year.
To support National Patient Safety Awareness Week, which starts Sunday, the American Society for Health Care Risk Management has developed free tip sheets and other resources to promote patient safety at hospitals.
The Occupational Safety and Health Administration will conduct focused inspections through June 9 to assess compliance and readiness at certain hospitals and skilled nursing facilities that treat or handle COVID-19 patients, the agency announced.
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response began distributing two COVID-19 antiviral pills directly to certain pharmacy-based clinics, federal health centers and long-term care facilities so their clinicians can prescribe them to…
Hospitals and health systems added 2,700 jobs in February, while U.S. jobs overall increased by 678,000, according to data released by the Bureau of Labor Statistics.
A shortage of BioFlex blood bags made by Fresenius Kabi is impacting an estimated 10%-15% of whole blood collections, America’s Blood Centers and Blood Centers of America reported.
B. Braun Medical Inc. has recalled five lots of 0.9% sodium chloride for injection due to fluid leakage or low fill volume, which could pose an infection risk to patients, the Food and Drug Administration announced.